Clinical Trial News and Research

RSS

Leading provider of eClinical solutions, epharmasolutions joins WIRB group of companies

WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies.

24 Sep 2014

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Inovio Pharmaceuticals, Inc. announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest.

24 Sep 2014

Seattle Children's Research Institute receives grant to improve health of infants with heart defects

The U.S. Food and Drug Administration's Office of Orphan Products Development has awarded Seattle Children's Research Institute a $1.6 million grant to lead a 4-year, multi-site clinical trial aimed at improving long-term health in infants born with a heart defect.

24 Sep 2014

GenoSpace awarded NIH grant to enable enhanced data access, cohort construction for biorepositories

GenoSpace, a precision medicine software company that has developed a comprehensive suite of tools to enable the broad use of genomic data in research and clinical care, today announced that it has been awarded Phase I of a Fast Track Small Business Innovation Research Grant from the National Institutes of Health to enable enhanced data access and cohort construction for biorepositories.

23 Sep 2014

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

TauRx Therapeutics Ltd has achieved its target enrolment of 700 subjects with mild Alzheimer's disease into the second of its two Phase III clinical trials of LMTX, a tau aggregation inhibitor, for the treatment of Alzheimer's disease.

22 Sep 2014

Phase IIa clinical trial data of ATL1102 in MS patients published in journal Neurology

Antisense Therapeutics is pleased to report the publication of previously generated Phase IIa clinical trial data on ATL1102 in the medical journal Neurology.

22 Sep 2014

Researchers test novel robotic system to improve prostate cancer biopsies

A novel robotic system that can operate inside the bore of an MRI scanner is currently being tested as part of a biomedical research partnership program at Brigham and Women's Hospital in Boston with the aim of determining if the robot, in conjunction with real-time MRI images, can make prostate cancer biopsies faster, more accurate, less costly, and less discomforting for the patient.

22 Sep 2014

Dry roasted peanuts more likely to trigger allergy risk

Dry roasted peanuts are more likely to trigger an allergy to peanuts than raw peanuts, suggests an Oxford University study involving mice.

22 Sep 2014

GWU researcher receives AHA grant to study diffuse brain swelling, injury in ICH patients

Shahram Majidi, M.D., a second-year resident in the Department of Neurology at the George Washington University School of Medicine and Health Sciences, received at $154K grant from the American Heart Association to study the presence of diffuse brain swelling and injury in patients with intracerebral hemorrhage (ICH).

22 Sep 2014

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has been awarded a contract valued at up to $24.7 million inclusive of options by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID).

19 Sep 2014

PCI acquires Biotec Services International

PCI is pleased to announce it has acquired Biotec Services International. Biotec is a leading provider of Clinical Trial Services and Temperature Controlled Pharmaceutical Services headquartered in Bridgend, Wales in the United Kingdom.

19 Sep 2014

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Lack of sleep can make you sick. And while everybody has the occasional restless night, for those who suffer from chronic insomnia — some 15 percent of older adults in the United States — that sleep loss can increase the risk for cardiovascular disease, hypertension, weight gain, type 2 diabetes, and even lead to an earlier death.

18 Sep 2014

Penn Medicine, Wistar Institute awarded NCI grants for four new melanoma research projects

Penn Medicine and The Wistar Institute have been awarded a prestigious $12.1 million SPORE grant from the National Cancer Institute. The five-year Specialized Programs of Research Excellence, or SPORE, grant will fund four new melanoma research projects that aim to translate fundamental laboratory discoveries into new therapeutics to treat melanoma and other skin cancers.

18 Sep 2014

Acclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for ETD treatment

Acclarent, Inc. announced today the launch of the ACCLARENT AERA Eustachian Tube Balloon Dilation System for the treatment of adult patients with Eustachian Tube Dysfunction (ETD), a condition marked by ear pain, pressure and dulled hearing.

18 Sep 2014

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).

18 Sep 2014

Benefits and risks of hatha yoga for people with bipolar disorder

Right now no one can say whether yoga provides clinical benefits to people with bipolar disorder, but in a new article in the Journal of Psychiatric Practice, researchers report survey responses they gathered from scores of people with the condition who practice yoga. What the collective testimony suggests is that yoga can be a substantial help, but it sometimes carries risks, too.

18 Sep 2014

Radiation and endocrine therapy combination may not be necessary for all HR+ breast cancer patients

Treatment with endocrine therapy and radiation therapy as part of breast conservation is the current standard of care for women with hormone-receptor positive (HR+) invasive breast cancer. A new study by researchers at Fox Chase Cancer Center, however, shows that combination may not be necessary for all patient populations with the disease.

17 Sep 2014

Vercise DBS System receives CE Mark approval for treatment of essential tremor

Boston Scientific Corporation has received CE Mark for the Vercise Deep Brain Stimulation (DBS) System for the treatment of tremor, including the most common form of this movement disorder known as essential tremor (ET).

17 Sep 2014

Janssen announces availability of PREZCOBIX for Canadians living with HIV

Janssen Inc. announced today that PREZCOBIX (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada. It is the first HIV treatment option available to patients that provides boosted darunavir in a single tablet.

17 Sep 2014

EnGeneIC receives award from Cancer Institute NSW for groundbreaking cancer research

EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, announced that, together with the Asbestos Disease Research Institute, it has received the 2014 Cancer Institute New South Wales Premier’s Award for Excellence in Translational Cancer Research.

17 Sep 2014

Clinical Trial News and Research

Leading provider of eClinical solutions, epharmasolutions joins WIRB group of companies

Inovio, GeneOne to advance DNA-based Ebola vaccine into phase I clinical trial

Seattle Children's Research Institute receives grant to improve health of infants with heart defects

GenoSpace awarded NIH grant to enable enhanced data access, cohort construction for biorepositories

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

Phase IIa clinical trial data of ATL1102 in MS patients published in journal Neurology

Researchers test novel robotic system to improve prostate cancer biopsies

Dry roasted peanuts more likely to trigger allergy risk

GWU researcher receives AHA grant to study diffuse brain swelling, injury in ICH patients

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

PCI acquires Biotec Services International

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Penn Medicine, Wistar Institute awarded NCI grants for four new melanoma research projects

Acclarent releases ACCLARENT AERA Eustachian Tube Balloon Dilation System for ETD treatment

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Benefits and risks of hatha yoga for people with bipolar disorder

Radiation and endocrine therapy combination may not be necessary for all HR+ breast cancer patients

Vercise DBS System receives CE Mark approval for treatment of essential tremor

Janssen announces availability of PREZCOBIX for Canadians living with HIV

EnGeneIC receives award from Cancer Institute NSW for groundbreaking cancer research

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer